Seller record · Telehealth service

MyFastRx

Fails 2 of 8 criteria. S3, pharmacy identification: The answers say orders are filled by licensed U.S. pharmacies and name none. The privacy policy names Manifest Pharmacy only in a mailing line for its program administrator, not as the pharmacy that fills orders. 1 more criterion also fails; see the table below.

At a glance

MyFastRxTelehealth service

6/8criteria passed
Price
Semaglutide first month $69, then $139 a month; tirzepatide first month $129, then $199
Sells
compounded semaglutide, compounded tirzepatide, NAD+ injection, and 1 more
FDA letters
None on file
Visit MyFastRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Florida telehealth service selling compounded semaglutide and tirzepatide at one price for every dose, with a first-month code and prepaid 3, 6 and 12-month plans, and NAD+ as an injection or nasal spray. No filling pharmacy is named.

Operating entity MyFastRx Health LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSMyFastRx's FAQ; MyFastRx's website
S2Prescription gatingPASSMyFastRx's onboard page on its checkout site; MyFastRx's special page; MyFastRx's FAQ
S3Pharmacy identificationFAILMyFastRx's FAQ; MyFastRx's privacy page; MyFastRx's terms
S4Compounding disclosurePASSMyFastRx's website; MyFastRx's semaglutide page; MyFastRx's FAQ
S5Analytical documentationFAILMyFastRx's special page; MyFastRx's FAQ
S6Business addressPASSMyFastRx's privacy page; MyFastRx's HIPAA page; MyFastRx's contact page
S7Price disclosurePASSMyFastRx's semaglutide page; MyFastRx's tirzepatide page; MyFastRx's save page; MyFastRx's NAD+ page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed U.S. medical provider reviews each medical intake and decides whether prescription treatment is appropriate, and prescriptions are issued at the provider's discretion.Source: MyFastRx's FAQ; MyFastRx's website.
S2PASSThe start button opens a four-step approval form whose first screen asks the buyer's state and contact details, with no payment screen before it. The answers page says the charge is made when the order is placed and refunded if the provider does not approve.Source: MyFastRx's onboard page on its checkout site; MyFastRx's special page; MyFastRx's FAQ.
S3FAILThe answers say orders are filled by licensed U.S. pharmacies and name none. The privacy policy names Manifest Pharmacy only in a mailing line for its program administrator, not as the pharmacy that fills orders.Source: MyFastRx's FAQ; MyFastRx's privacy page; MyFastRx's terms.
S4PASSThe footer on every page states that the medications offered are compounded and not FDA-approved, and the answers on the home page and the answers page say the same.Source: MyFastRx's website; MyFastRx's semaglutide page; MyFastRx's FAQ.
S5FAILThe pages say compounding uses accredited 503A and 503B pharmacies, and no certificate of analysis or lot document is published.Source: MyFastRx's special page; MyFastRx's FAQ.
S6PASSMyFastRx Health LLC at 20423 SR 7 Ste. F6 #227, Boca Raton, FL 33498, printed in the privacy policy and the HIPAA notice. The contact page gives the same address as a mailing address only.Source: MyFastRx's privacy page; MyFastRx's HIPAA page; MyFastRx's contact page.
S7PASSCompounded semaglutide at $139 a month, with a first month at $69 under a code for new customers, or $99 a month billed $297 for 3 months, $89 a month billed $534 for 6 months and $79 a month billed $948 for 12 months. Compounded tirzepatide at $199 a month, with a first month at $129 under the same code, or $166 a month billed $498 for 3 months, $149 a month billed $894 for 6 months and $124 a month billed $1,488 for 12 months, the same price at every dose. NAD+ as an injection or nasal spray at $139 a month, or $99 a month billed $297 for 3 months.Source: MyFastRx's semaglutide page; MyFastRx's tirzepatide page; MyFastRx's save page; MyFastRx's NAD+ page.
S8PASSNo FDA warning letter names MyFastRx or MyFastRx Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+ injection, NAD+ nasal spray.

Visit MyFastRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.